UNSPSC 51131636: Efegatran

This classification denotes a protease inhibitor and anticoagulant agent with the molecular formula C21H32N6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, VT0VK2474K chemically known as l-prolinamide, n-methyl-d-phenylalanyl-n-(4-((aminoiminomethyl)amino)-1-formylbutyl)-, (s)- but generally known as efegatran, which bears US NIH Compound Identifier 122267. European Medicines Agency schedules Efegatran in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06464MIG.

UNSPSC 51131636 Efegatran is a Commodity code with minimal recent state and local procurement activity. The single posted opportunity under this code is a Sourcewell RFP for Law Enforcement Equipment, which is not efegatran (a thrombin inhibitor pharmaceutical) but rather broad law enforcement tactical and operational gear. The mismatch between the code's pharmaceutical designation and the actual solicitation suggests either a tagging error in the source or that efegatran procurement through state and local channels is not currently active.

Sourcewell, a Minnesota-based cooperative purchasing vehicle operating under Washington state law (RCW 39.34), issued RFP 061626 on May 12, 2026 with a response date of June 16, 2026 at 3:30 p.m. Central Time. The procurement framework encompasses Franklin County, Grant County, Grays Harbor County, Chelan County, and Yakima County in Washington, along with other jurisdictions and public entities across the United States and Canada. The resulting contract is intended for use by thousands of governmental agencies, higher education institutions, K-12 school districts, nonprofit organizations, and tribal governments through Sourcewell's participating addendum structure. No set-aside designations, specific award values, or incumbent vendors were disclosed in available documentation. Submissions are due exclusively through the Sourcewell Procurement Portal; vendors must create a free account to access all solicitation documents and the Q&A channel.